...
首页> 外文期刊>Journal of Internal Medicine >Scavenger receptor AI/II truncation, lung function and COPD: a large population-based study.
【24h】

Scavenger receptor AI/II truncation, lung function and COPD: a large population-based study.

机译:清道夫受体AI / II截短,肺功能和COPD:一项基于人群的大型研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: The scavenger receptor A-I/II (SRA-I/II) on alveolar macrophages is involved in recognition and clearance of modified lipids and inhaled particulates. A rare variant of the SRA-I/II gene, Arg293X, truncates the distal collagen-like domain, which is essential for ligand recognition. We tested whether the Arg293X variant is associated with reduced lung function and risk of chronic obstructive pulmonary disease (COPD) in the general population. METHODS: We genotyped 48,741 individuals from the adult Danish general population for Arg293X, and recorded lung function and spirometry-defined COPD. RESULTS: Arg293X homozygotes (n = 5) and heterozygotes (n = 587), compared with noncarriers (n = 48,149), had a 6% and 1% reduction in predicted percentage of forced vital capacity (FVC % predicted) (P = 0.05) and a nonsignificant 7% and 1% reduction in predicted percentage of forced expiratory volume in one second (FEV(1) % predicted) (P = 0.06), respectively. The Arg293X genotype interacted with gender (P = 0.004) and alpha(1) -antitrypsin MZ heterozygosity (P = 0.049), but not with superoxide dismutase-3 E1I1 heterozygosity (P = 0.11) in determining FEV(1) % predicted. Amongst men, FEV(1) % predicted and FVC % predicted were both reduced by 4% (P = 0.0004 and P = 0.0003, respectively) in Arg293X heterozygotes compared with noncarriers. Corresponding values were 14% (P = 0.03) and 11% (P = 0.04) amongst MZ heterozygotes, and 9% (P = 0.03) and 8% (P = 0.04) amongst E1I1 heterozygotes, compared with noncarriers. Lung function did not differ between Arg293X heterozygotes and noncarriers amongst females or individuals without MZ and E1I1. Arg293X heterozygosity was associated with spirometry-defined COPD amongst men [odds ratio (95% confidence interval): 1.7 (1.1-2.4)], but not with COPD in the whole cohort or in any other subgroup. CONCLUSIONS: SRAI/II Arg293X heterozygotes have reduced lung function and increased COPD risk amongst men. They also have reduced lung function amongst individuals heterozygous for the alpha(1)-antitrypsin MZ and superoxide dismutase-3 E1I1 genotypes.
机译:目的:肺泡巨噬细胞上的清道夫受体A-I / II(SRA-I / II)参与识别和清除修饰的脂质和吸入颗粒。 SRA-I / II基因的罕见变体Arg293X截短了远端胶原样结构域,这对于配体识别至关重要。我们测试了一般人群中Arg293X变体是否与肺功能降低和慢性阻塞性肺疾病(COPD)风险相关。方法:我们对来自丹麦成年普通人群的Arg293X进行了基因型分析,共48741例,并记录了肺功能和肺活量测定定义的COPD。结果:与非携带者(n = 48,149)相比,Arg293X纯合子(n = 5)和杂合子(n = 587)的强制肺活量预测百分比(FVC预测百分比)降低了6%和1%(P = 0.05) ),在一秒内强迫呼气量的预测百分比分别降低了7%和1%(FEV(1)%预测)(P = 0.06)。 Arg293X基因型与性别(P = 0.004)和alpha(1)-抗胰蛋白酶MZ杂合度(P = 0.049)相互作用,但与超氧化物歧化酶3 E1I1杂合度(P = 0.11)不相关,从而确定预测的FEV(1)%。在男性中,与非携带者相比,Arg293X杂合子中预测的FEV(1)%和预测的FVC%都降低了4%(分别为P = 0.0004和P = 0.0003)。与非携带者相比,MZ杂合子中相应的值分别为14%(P = 0.03)和11%(P = 0.04),以及E1I1杂合子中的9%(P = 0.03)和8%(P = 0.04)。在女性或没有MZ和E1I1的个体中,Arg293X杂合子与非携带者之间的肺功能没有差异。 Arg293X杂合性与男性肺活量测定定义的COPD相关[比值比(95%置信区间):1.7(1.1-2.4)],但在整个队列或任何其他亚组中均与COPD不相关。结论:SRAI / II Arg293X杂合子降低了男性的肺功能并增加了COPD风险。他们还降低了个体间对于α(1)-抗胰蛋白酶MZ和超氧化物歧化酶3 E1I1基因型杂合的个体的肺功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号